TY - JOUR
T1 - Daam2 Regulates Myelin Structure and the Oligodendrocyte Actin Cytoskeleton through Rac1 and Gelsolin
AU - Cristobal, Carlo D.
AU - Wang, Chih Yen
AU - Zuo, Zhongyuan
AU - Smith, Joshua A.
AU - Lindeke-Myers, Aaron
AU - Bellen, Hugo J.
AU - Lee, Hyun Kyoung
N1 - Funding Information:
This work was supported by grants from the National Multiple Sclerosis Society (RG-1907-34551; to H.K.L.), National Institutes of Health (NIH)/ National Institute of Neurological Disorders and Stroke (R01NS110859; to H.K.L.), Cynthia and Anthony G. Petrello Endowment and the Mark A. Wallace Endowment established by an anonymous donor (H.K.L.). Electron microscopy, behavioral assays, and morphological analysis were supported in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under Award P50HD103555 for the use of the Baylor College of Medicine Intellectual and Developmental Disabilities Research Center (BCM IDDRC) Neurobehavior and Neurovisualization Cores. We thank Diego Cortes for technical assistance, Dr. Surabi Veeraragavan at BCM for assistance in behavioral assays, Dr. Jacqueline Trotter at the University of Mainz for Oli-Neu cell lines, and Dr. Seung-Hee Yoo at the University of Texas Health Science Center at Houston for technical assistance in biochemical assays. Diagrams were made with images from Biorender. *C.D.C. and C.-Y.W. contributed equally to this work. The authors declare no competing financial interests. Correspondence should be addressed to Hyun Kyoung Lee at [email protected]. https://doi.org/10.1523/JNEUROSCI.1517-21.2022 Copyright © 2022 the authors
Publisher Copyright:
Copyright © 2022 the authors
PY - 2022/3/2
Y1 - 2022/3/2
N2 - Myelin is essential to neuronal health and CNS function, and oligodendrocytes (OLs) undergo a complex process of cytoskeletal remodeling to form compact myelin sheaths. We previously discovered that a formin protein, Dishevelled associated activator of morphogenesis 2 (Daam2), suppresses OL differentiation through Wnt signaling; however, its role in cytoskeletal control remains unknown. To investigate this, we used OL-specific Daam2 conditional knockout (Daam2 cKO) mice of either sex and found myelin decompaction during an active period of myelination in postnatal development and motor coordination deficits in adulthood. Using primary OL cultures, we found Daam2-depleted OLs showed morphologic dysregulation during differentiation, suggesting that Daam2 regulates the OL cytoskeleton. In vivo screening identified the actin regulators Rac1 and Gelsolin as possible effectors in Daam2-deficient OL cytoskeletal regulation. Using gain-of-function and loss-of-function (LOF) experiments in primary OLs, we found that Rac1 and Gelsolin operate downstream of Daam2 in OL differentiation, with Gelsolin and Daam2 promoting and inhibiting membrane spreading during late differentiation, respectively. In vivo experiments using Daam2 cKO mice revealed increased protein levels of Gelsolin in the developing white matter with no change in RNA levels, suggesting that Daam2 acts in a posttranslational manner to suppress Gelsolin levels. In vitro biochemical studies show Daam2 induces Gelsolin ubiquitination and degradation in OLs. Together, our studies show Daam2 is essential for formation of functional myelin through modulation of Gelsolin levels to regulate the OL cytoskeleton. These findings further demonstrate the critical role of cytoskeletal dynamics in myelination and reveal novel avenues for treatment of a variety of white matter diseases.
AB - Myelin is essential to neuronal health and CNS function, and oligodendrocytes (OLs) undergo a complex process of cytoskeletal remodeling to form compact myelin sheaths. We previously discovered that a formin protein, Dishevelled associated activator of morphogenesis 2 (Daam2), suppresses OL differentiation through Wnt signaling; however, its role in cytoskeletal control remains unknown. To investigate this, we used OL-specific Daam2 conditional knockout (Daam2 cKO) mice of either sex and found myelin decompaction during an active period of myelination in postnatal development and motor coordination deficits in adulthood. Using primary OL cultures, we found Daam2-depleted OLs showed morphologic dysregulation during differentiation, suggesting that Daam2 regulates the OL cytoskeleton. In vivo screening identified the actin regulators Rac1 and Gelsolin as possible effectors in Daam2-deficient OL cytoskeletal regulation. Using gain-of-function and loss-of-function (LOF) experiments in primary OLs, we found that Rac1 and Gelsolin operate downstream of Daam2 in OL differentiation, with Gelsolin and Daam2 promoting and inhibiting membrane spreading during late differentiation, respectively. In vivo experiments using Daam2 cKO mice revealed increased protein levels of Gelsolin in the developing white matter with no change in RNA levels, suggesting that Daam2 acts in a posttranslational manner to suppress Gelsolin levels. In vitro biochemical studies show Daam2 induces Gelsolin ubiquitination and degradation in OLs. Together, our studies show Daam2 is essential for formation of functional myelin through modulation of Gelsolin levels to regulate the OL cytoskeleton. These findings further demonstrate the critical role of cytoskeletal dynamics in myelination and reveal novel avenues for treatment of a variety of white matter diseases.
UR - http://www.scopus.com/inward/record.url?scp=85125681341&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125681341&partnerID=8YFLogxK
U2 - 10.1523/JNEUROSCI.1517-21.2022
DO - 10.1523/JNEUROSCI.1517-21.2022
M3 - Article
C2 - 35101966
AN - SCOPUS:85125681341
SN - 0270-6474
VL - 42
SP - 1679
EP - 1691
JO - Journal of Neuroscience
JF - Journal of Neuroscience
IS - 9
ER -